Efficacy and safety of treatment with or without pertuzumab for HER2-positive breast cancer: A meta-analysis

We conducted a meta-analysis to systematically evaluate the efficacy and safety of treatment with or without pertuzumab for human epidermal growth factor receptor-2 -positive (HER2)-positive breast cancer and provided evidence-based reference for clinical use. METHODS: The Cochrane Library, PubMed,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xuan, Li, Yuqing, Lin, Mingfei, Lu, Yufu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237690/
https://www.ncbi.nlm.nih.gov/pubmed/37266600
http://dx.doi.org/10.1097/MD.0000000000033925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237690/
https://www.ncbi.nlm.nih.gov/pubmed/37266600
http://dx.doi.org/10.1097/MD.0000000000033925

Ejemplares similares